Assembly of complete genome sequences of negative-control and experimental strain variants of staphylococcus aureus ATCC BAA-39 selected under the effect of the drug FS-1, which induces antibiotic resistance reversion
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Joubert, Monique
|
|
| dc.contributor.author | Reva, Oleg N.
|
|
| dc.contributor.author | Korotetskiy, Ilya S.
|
|
| dc.contributor.author | Shvidko, Sergey V.
|
|
| dc.contributor.author | Shilov, Sergey V.
|
|
| dc.contributor.author | Jumagaziyeva, Ardak B.
|
|
| dc.contributor.author | Kenesheva, Sabina T.
|
|
| dc.contributor.author | Suldina, Natalya A.
|
|
| dc.contributor.author | Ilin, Aleksandr I.
|
|
| dc.date.accessioned | 2020-08-07T11:01:46Z | |
| dc.date.available | 2020-08-07T11:01:46Z | |
| dc.date.issued | 2019-07 | |
| dc.description.abstract | Staphylococcus aureus ATCC BAA-39 is the reference organism for a multidrug-resistant Staphylococcus aureus (MRSA) strain that was used to study druginduced resistance reversion by an iodine-containing nanomolecular complex, FS-1. PacBio sequencing was performed on both the experimental and control strains, followed by genome assembly, variant calling, and DNA modification profiling. | en_ZA |
| dc.description.department | Biochemistry | en_ZA |
| dc.description.department | Genetics | en_ZA |
| dc.description.department | Microbiology and Plant Pathology | en_ZA |
| dc.description.librarian | pm2020 | en_ZA |
| dc.description.sponsorship | Ministry of Industry and Infrastructural Development of the Republic of Kazakhstan and South African National Research Foundation (NRF). | en_ZA |
| dc.description.uri | https://mra.asm.org | en_ZA |
| dc.identifier.citation | Joubert M, Reva ON, Korotetskiy IS, Shvidko SV, Shilov SV, Jumagaziyeva AB, Kenesheva ST, Suldina NA, Ilin AI. 2019. Assembly of complete genome sequences of negative-control and experimental strain variants of Staphylococcus aureus ATCC BAA-39 selected under the effect of the drug FS-1, which induces antibiotic resistance reversion. Microbiology Resource Announcements 8:e00579-19. https://doi.org/10.1128/MRA.00579-19. | en_ZA |
| dc.identifier.issn | 2576-098X (online) | |
| dc.identifier.other | 10.1128/MRA.00579-19 | |
| dc.identifier.uri | http://hdl.handle.net/2263/75608 | |
| dc.language.iso | en | en_ZA |
| dc.publisher | American Society for Microbiology | en_ZA |
| dc.rights | © 2019 Joubert et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. | en_ZA |
| dc.subject | FS-1 Drug | en_ZA |
| dc.subject | Staphylococcus aureus | en_ZA |
| dc.subject | Antibiotic resistance reversal | en_ZA |
| dc.subject | Strain analysis | en_ZA |
| dc.subject | Genome | en_ZA |
| dc.subject | Multidrug-resistant Staphylococcus aureus (MRSA) | en_ZA |
| dc.title | Assembly of complete genome sequences of negative-control and experimental strain variants of staphylococcus aureus ATCC BAA-39 selected under the effect of the drug FS-1, which induces antibiotic resistance reversion | en_ZA |
| dc.type | Article | en_ZA |
